Your browser doesn't support javascript.
loading
Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria.
Kwambana-Adams, Brenda A; Amaza, Rahab C; Okoi, Catherine; Rabiu, Murtala; Worwui, Archibald; Foster-Nyarko, Ebenezer; Ebruke, Bernard; Sesay, Abdul K; Senghore, Madikay; Umar, Abdullahi S; Usman, Rabi; Atiku, Adamu; Abdullahi, Garba; Buhari, Yahaya; Sani, Rabiu; Bako, Husaini U; Abdullahi, Bashir; Yarima, Alliyu I; Sikiru, Badaru; Moses, Aderinola Olaolu; Popoola, Michael O; Ekeng, Eme; Olayinka, Adebola; Mba, Nwando; Kankia, Adamu; Mamadu, Ibrahim N; Okudo, Ifeanyi; Stephen, Mary; Ronveaux, Olivier; Busuttil, Jason; Mwenda, Jason M; Abdulaziz, Mohammed; Gummi, Sulaiman A; Adedeji, Adebayo; Bita, Andre; Omar, Linda; Djingarey, Mamoudou Harouna; Alemu, Wondimagegnehu; D'Alessandro, Umberto; Ihekweazu, Chikwe; Antonio, Martin.
Afiliação
  • Kwambana-Adams BA; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Amaza RC; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Okoi C; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Rabiu M; Ahmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
  • Worwui A; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Foster-Nyarko E; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Ebruke B; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Sesay AK; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Senghore M; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Umar AS; Zamfara State Ministry of Health, Gusau, Nigeria.
  • Usman R; Zamfara State Ministry of Health, Gusau, Nigeria.
  • Atiku A; Zamfara State Ministry of Health, Gusau, Nigeria.
  • Abdullahi G; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Buhari Y; Ahmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
  • Sani R; Ahmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
  • Bako HU; Ahmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
  • Abdullahi B; Ahmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
  • Yarima AI; Ahmad Sani Yariman Bakura Specialist Hospital Gusau, Zamfara State, Gusau, Nigeria.
  • Sikiru B; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Moses AO; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Popoola MO; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Ekeng E; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Olayinka A; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Mba N; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Kankia A; World Health Organization, Country Office Nigeria, Abuja, Nigeria.
  • Mamadu IN; World Health Organization, Country Office Nigeria, Abuja, Nigeria.
  • Okudo I; World Health Organization, Country Office Nigeria, Abuja, Nigeria.
  • Stephen M; World Health Organization, Country Office Nigeria, Abuja, Nigeria.
  • Ronveaux O; World Health Organization, Geneva, Switzerland.
  • Busuttil J; UK-Public Health Rapid Support Team, Public Health England, Salisbury, UK.
  • Mwenda JM; World Health Organization, Regional office for Africa, Brazzaville, Congo.
  • Abdulaziz M; Africa Centres for Diseases Control and Prevention, Addis Ababa, Ethiopia.
  • Gummi SA; Zamfara State Ministry of Health, Gusau, Nigeria.
  • Adedeji A; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Bita A; World Health Organization Inter-Country Support Teams for West Africa, Ouagadougou, Burkina Faso.
  • Omar L; World Health Organization, Regional office for Africa, Brazzaville, Congo.
  • Djingarey MH; World Health Organization, Regional office for Africa, Brazzaville, Congo.
  • Alemu W; World Health Organization, Country Office Nigeria, Abuja, Nigeria.
  • D'Alessandro U; Disease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia.
  • Ihekweazu C; Nigeria Center for Disease Control, Abuja, Nigeria.
  • Antonio M; World Health Organization, Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Atlantic Boulevard, Fajara, PO Box 273, Banjul, The Gambia. mantonio@mrc.gm.
Sci Rep ; 8(1): 14194, 2018 09 21.
Article em En | MEDLINE | ID: mdl-30242204

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neisseria meningitidis Sorogrupo C / Meningite Meningocócica Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neisseria meningitidis Sorogrupo C / Meningite Meningocócica Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article